Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA260770
Max Phase: Preclinical
Molecular Formula: C19H17ClN2O2
Molecular Weight: 340.81
Molecule Type: Small molecule
Associated Items:
ID: ALA260770
Max Phase: Preclinical
Molecular Formula: C19H17ClN2O2
Molecular Weight: 340.81
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1ccc(Cn2ccc(OCc3ccccc3)cc2=O)c(Cl)c1
Standard InChI: InChI=1S/C19H17ClN2O2/c20-18-10-16(21)7-6-15(18)12-22-9-8-17(11-19(22)23)24-13-14-4-2-1-3-5-14/h1-11H,12-13,21H2
Standard InChI Key: VDPUOHFJPAWBKO-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 340.81 | Molecular Weight (Monoisotopic): 340.0979 | AlogP: 3.71 | #Rotatable Bonds: 5 |
Polar Surface Area: 57.25 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.43 | CX LogP: 3.18 | CX LogD: 3.18 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.72 | Np Likeness Score: -1.20 |
1. Tipparaju SK, Joyasawal S, Forrester S, Mulhearn DC, Pegan S, Johnson ME, Mesecar AD, Kozikowski AP.. (2008) Design and synthesis of 2-pyridones as novel inhibitors of the Bacillus anthracis enoyl-ACP reductase., 18 (12): [PMID:18499454] [10.1016/j.bmcl.2008.05.004] |
Source(1):